Back to search

University of Edinburgh

Bugs and the Bs: the obese microbiome causes B cell dysfunction

Abstract

dc:description.abstract

Metabolic inflammation is a chronic, systemic inflammatory state that occurs during obesity and aging. This inflammation, particularly within the ‘insulin sensitive tissues’ of the liver, skeletal muscle and visceral adipose depots, promotes insulin resistance - a key mechanism in the development of age and obesity associated disease. Over the last decade, B cells have emerged as important mediators of metabolic inflammation, particularly in the visceral adipose tissue where they can promote or prevent inflammation depending on context. Both aging and obesity alter B cell populations, leading to impairment of their protective functions and the development of pathological effects such as the production of IgG class antibodies. Despite a growing appreciation of their importance, the reasons for B cell dysfunction during obesity and aging remain poorly understood. During health, B cells have a well-established role in regulating the gut microbiome, which in turn can reciprocally influence B cell functions. Microbial dysbiosis during obesity and aging has been implicated as a broader trigger for metabolic inflammation, and breakdown in B cell/microbiome interactions are thought to contribute to the development of some autoimmune diseases. However, the relationship between the obese microbiome and B cells has not been extensively studied. My hypothesis is that alterations in the gut flora during obesity promote B cell dysfunction and contribute to the development of insulin resistance. To investigate this, I used antibiotics and microbiome transfers to manipulate the gut flora in a mouse dietary induced obesity model. I demonstrate that high-fat diet feeding causes an aberrant accumulation of IgG-producing plasma cells in the bone marrow. This led to increased circulating IgG concentrations and accumulation of IgG specifically within visceral adipose tissue. Depletion of commensal bacteria in obese mice prevented IgG accumulation, and transfer of gut flora between mice was sufficient to induce accumulations of IgG-producing plasma cells, demonstrating that the obese microbiome was driving altered B cell function. I found that mice originating from a different barrier room failed to develop obesity-associated IgG, leading to the conclusion that a distinct ‘seed’ microbiome is required to induce IgG production. I leveraged this to identify possible bacterial culprits by comparing the gut microbial populations between IgG-producing and non-IgG producing mice using 16s ribosomal-RNA sequencing. Next, I investigated the mechanisms by which B cells are activated during high-fat diet, leading to their migration and differentiation into IgG producing bone marrow plasma cells. Surprisingly, time-course experiments revealed no evidence of a systemic germinal centre or extrafollicular B cell response. There were increases in B cell division in the peritoneal cavity, however cell tracking experiments did not suggest this was the source of the IgG producing plasma cells. As a result, the location and mechanisms of B cell activation during obesity remain unknown. To understand the link between obesity-associated IgG, the microbiome and insulin resistance in my model, I measured fasting glucose, fasting insulin and performed glucose tolerance tests. Depleting the microbiome markedly improved fasting glucose, however this was not due to a reduction in IgG concentration. Mixed effect modelling identified a significant association between IgG and fasted insulin, however low doses of IgG purified from obese mice did not raise insulin concentration or affect glucose tolerance in recipients. Taken together, this suggests that an increase in IgG quantity rather than pathogenicity during obesity predisposes to insulin resistance. Finally, by analysing human serum samples I observed a correlation between BMI and serum IgG concentration in young males, demonstrating that IgG may contribute to metabolic inflammation in humans. The work in this thesis demonstrates that obesity-induced gut dysbiosis is a driver of B cell dysfunction, promoting abnormal IgG production. I show evidence suggesting this IgG promotes insulin resistance in mouse models, a phenomenon which has also been demonstrated by other investigators. Overall, it highlights both B cells and the microbiome as potentially modifiable targets in the management of obesity and metabolic inflammation.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Daley, Alexander David
Advisors dc:contributor.advisor
  • Benezech, Cecile
  • Stimson, Roland
  • Yao, Chengcan
  • Cowan, Graeme

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Daley, Alexander David. Bugs and the Bs: the obese microbiome causes B cell dysfunction. 2026. https://era.ed.ac.uk/handle/1842/44989